PT-141

What it is

PT-141 is the research designation for bremelanotide, a synthetic cyclic heptapeptide in the melanocortin family. 10 mg lyophilized vial. This sheet does not describe clinical indications or use in people.

What research explores

• Binding at melanocortin (MC) receptors
• Pharmacology of cyclic α-MSH analogs
• Signaling assays in cell and animal systems
• Stability and identity of cyclic heptapeptides

Studies

Regulated clinical literature exists under the INN bremelanotide in specific contexts; CodePept sells RUO reference material only and does not reproduce approved indications or class marketing.

Reported effects

MC-receptor literature describes physiological responses in models and in medically supervised trials — outside the scope of this shop. No sexual or wellness claims.

In the literature

Published clinical protocols refer to regulated medicinal products, not this RUO vial. CodePept does not publish a protocol.

Specs

Format

Lyophilized powder

Quantity

10 mg

Store per the lot sheet, typically refrigerated and protected from light.

Lot: as stated by the manufacturer on the vial

Manufacturer COA — shown when the file exists in the data

Research use

Research use only (RUO). Not for human consumption.